Latest filing published 06 Oct 2026 for Pelthos Therapeutics Inc., €10k.
Not enough history yet: 0 closed purchases, at least 2 are needed.
All filings by Ezra M. Friedberg on record concern Pelthos Therapeutics Inc. In total, 17 filings cover trades dated from 21 February 2024 to 2 October 2026.
In open-market terms, that means 1 purchase worth €92k on one side and 9 sales worth €276k on the other. Netting one side against the other leaves €184k of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 3 share grants and 2 option exercises. Since January 2026: no purchases and 5 sales on the market.
The newest entry dates from 6 October 2026: an open-market sale of €10k, in Pelthos Therapeutics Inc. The latest purchase dates back some time: it was published 956 days ago, on 12 March 2024. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations